Lab 901 was sold to Agilent Technologies, a US listed company, in 2011. The original investment by Archangels was made in 2002.

Lab901’s revolutionary ScreenTape product automates a traditional bio-analysis process used by thousands of scientists and clinicians around the world. ScreenTape enables diagnostic and life science research labs to achieve rapid and accurate results effortlessly and is now sold across 5 continents.

YEAR OF EXIT
2011